BRIEF-GSK, Biological E in JV to develop vaccine for India, other developing countries

LONDON Mon Jan 28, 2013 4:04am EST

Related Topics

LONDON Jan 28 (Reuters) - GlaxoSmithKline Plc : * Gsk and biological e. announce joint venture to develop combination vaccine

for India and other developing countries * Jv will bear development costs for candidate vaccine expected to enter phase

1 development in next 2 years

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.